Professor
University of Toronto
Toronto, Ontario, Canada
Dr. Christine Allen is a full professor at the University of Toronto (U of T) and an internationally recognized leader with more than 170 publications in drug formulation and development. She is a member of the Scientific Leadership Team of the Acceleration Consortium, a strategic initiative awarded $200M from the Canada First Research Excellence Fund. She has received numerous awards, and is a fellow of the American Institute for Medical and Biological Engineering, and the Canadian Academy of Health Sciences.
Christine is committed to the translation and commercialization of her research. She is a co-founder and CEO of Intrepid Labs Inc., a company accelerating pharmaceutical drug development through integration of AI and robotics. She is also a co-founder and board member at Nanovista Inc. Her lab at U of T is deeply engaged in industry partnerships, playing a key role in advancing drugs from early-stage research to clinical trials.
Her leadership has been pivotal in several scientific societies, notably as President of the Controlled Release Society and the Canadian Society for Pharmaceutical Sciences. In academia, her roles have included the inaugural Associate Vice-President and Vice Provost Strategic Initiatives and Interim Dean of the Leslie Dan Faculty of Pharmacy.
Disclosure information not submitted.
Keynote: Accelerating Formulation Development via Machine Learning and Automation
Monday, October 21, 2024
1:30 PM – 2:30 PM MT